Xiaobing Chen

1.1k total citations
43 papers, 817 citations indexed

About

Xiaobing Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaobing Chen has authored 43 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Xiaobing Chen's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (4 papers). Xiaobing Chen is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (4 papers). Xiaobing Chen collaborates with scholars based in China, United States and United Kingdom. Xiaobing Chen's co-authors include Bin Cheng, Juan Xia, Lin Ren, Jiayan Li, Xiaodan Chen, Beibei Chen, Tong Wu, Xianyue Ren, Qinchao Hu and Yuzhou Zhao and has published in prestigious journals such as The Science of The Total Environment, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Xiaobing Chen

39 papers receiving 811 citations

Peers

Xiaobing Chen
Eun Ji Lee South Korea
Jian Xiao China
Hao Zhou China
Xue Leng China
Xiaobing Chen
Citations per year, relative to Xiaobing Chen Xiaobing Chen (= 1×) peers Yiting Tang

Countries citing papers authored by Xiaobing Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Chen more than expected).

Fields of papers citing papers by Xiaobing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Chen. The network helps show where Xiaobing Chen may publish in the future.

Co-authorship network of co-authors of Xiaobing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Chen. A scholar is included among the top collaborators of Xiaobing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Chen. Xiaobing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hu, Hui-Hui, Huifang Lv, Jianzheng Wang, et al.. (2025). Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling Pathway. Recent Patents on Anti-Cancer Drug Discovery. 21(1). 14–30.
3.
Wang, Shuwu, Ying Zhou, Shaopeng Wang, et al.. (2024). Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer. Journal of Medicinal Chemistry. 67(18). 16165–16184. 6 indexed citations
4.
Zhang, Siyuan, Lixuan Wang, Yingyao Chen, et al.. (2024). Radiation‐induced exosomes promote oral squamous cell carcinoma progression via enhancing SLC1A5 ‐glutamine metabolism. Journal of Oral Pathology and Medicine. 53(7). 458–467. 4 indexed citations
5.
Chen, Xiaobing, et al.. (2024). Intracerebroventricular infusion of secretoneurin inhibits neuronal NLRP3-Apoptosis pathway and preserves learning and memory after cerebral ischemia. Neurochemistry International. 178. 105770–105770. 1 indexed citations
6.
Chen, Xiaobing, Wei Li, Dong Xu, et al.. (2023). α-Conotoxin recombinant protein ImI-AFP3 efficiently inhibits the growth and migration of lung cancer cells. Protein Expression and Purification. 215. 106405–106405.
7.
Wang, Saiqi, et al.. (2023). Utilizing natural products as new E3 ligase ligands for targeted protein degradation. Chinese Journal of Natural Medicines. 21(12). 881–883. 2 indexed citations
8.
Zhao, Jing, et al.. (2023). Identification of neutrophil extracellular trap-driven gastric cancer heterogeneity and C5AR1 as a therapeutic target. Acta Biochimica et Biophysica Sinica. 56(4). 538–550. 3 indexed citations
9.
Zou, Jun, Hongmin Zhang, Hao Liu, et al.. (2023). Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice. The Science of The Total Environment. 889. 164307–164307. 22 indexed citations
10.
Wang, Saiqi, Qiu‐Xu Teng, Shuai Wang, et al.. (2022). Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor. Acta Pharmaceutica Sinica B. 12(8). 3263–3280. 24 indexed citations
11.
Yuan, Weiwei, Shanshan Hou, Huahua Li, et al.. (2022). The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis. Frontiers in Pharmacology. 13. 918588–918588. 15 indexed citations
12.
Wei, Qing, Ting Xu, Xiaotian Zhang, et al.. (2021). A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patients. Gastroenterology report. 9(4). 339–349. 5 indexed citations
13.
Ma, Fei, et al.. (2021). Various Kinds of Functional Digestive Tract Reconstruction Methods After Proximal Gastrectomy. Frontiers in Oncology. 11. 685717–685717. 14 indexed citations
14.
Ren, Lin, Xiaodan Chen, Xiaobing Chen, et al.. (2020). Mitochondrial Dynamics: Fission and Fusion in Fate Determination of Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology. 8. 580070–580070. 105 indexed citations
15.
Meng, Yuan, Xiaobing Chen, Yitang Sun, et al.. (2020). ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression. Acta Pharmaceutica Sinica B. 10(8). 1426–1439. 51 indexed citations
16.
Jia, Yan‐Long, et al.. (2016). Comparative Proteomic Analysis of Bleomycin-induced Pulmonary Fibrosis Based on Isobaric Tag for Quantitation. The American Journal of the Medical Sciences. 353(1). 49–58. 10 indexed citations
17.
Shen, Xiaokun, Beibei Chen, Bojian Xie, et al.. (2015). A systematic analysis of the resistance and sensitivity of HER2YVMAreceptor tyrosine kinase mutant to tyrosine kinase inhibitors in HER2-positive lung cancer. Journal of Receptors and Signal Transduction. 36(1). 89–97. 7 indexed citations
18.
Fu, Qiang, Jing Cheng, Yebo Gao, et al.. (2014). Protease-Activated Receptor 4: A Critical Participator in Inflammatory Response. Inflammation. 38(2). 886–895. 21 indexed citations
19.
Zhou, Guang‐Zhou, et al.. (2013). A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells. Pharmaceutical Biology. 52(1). 111–116. 35 indexed citations
20.
Yan, Jiaqin, Mingzhi Zhang, Junhui Zhang, Xiaobing Chen, & Xudong Zhang. (2011). Helicobacter pylori infection promotes methylation of WWOX gene in human gastric cancer. Biochemical and Biophysical Research Communications. 408(1). 99–102. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026